C-Jun N-terminal kinase pathway activation in human and experimental cerebral contusion

Journal of Neuropathology and Experimental Neurology

Volumn 68, Issue 9, 2009, Pages 964-971

  Ortolano, Fabrizio ^a,b   Colombo, Alessio ^a   Zanier, Elisa Roncati ^a,b   Sclip, Allessandra ^a   Longhi, Luca ^a,b   Perego, Carlo ^a   Stocchetti, Nino ^b   Borsello, Tiziana ^a   De Simoni, Maria Grazia ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Brain contusion; C Jun N terminal kinase pathway; D JNKI1; Neuroprotection, Traumatic brain injury

Indexed keywords

SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CONTUSION; BRAIN CORTEX; BRAIN PERFUSION; BRAIN TISSUE; CELL LOSS; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MOTOR PERFORMANCE; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

ADULT; AGED; ANIMALS; BLOTTING, WESTERN; BRAIN INJURIES; ENZYME ACTIVATION; ENZYME INHIBITORS; FEMALE; HUMANS; IN SITU NICK-END LABELING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; SIGNAL TRANSDUCTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70349212110     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181b20670     Document Type: Article

References (43)

1. Narayan RK, Michel ME, Ansell B, et al. Clinical trials in head injury. J Neurotrauma 2002;19:503-57
2. Clark RS, Chen J, Watkins SC, et al. Apoptosis-suppressor gene bcl-2 expression after traumatic brain injury in rats. J Neurosci 1997;17: 9172-82
3. Clark RS, Kochanek PM, Chen M, et al. Increases in Bcl-2 and cleavage of caspase-1 and caspase-3 in human brain after head injury. FASEB J 1999;13:813-21
4. Fox GB, Fan L, Levasseur RA, et al. Sustained sensory/motor and cognitive deficits with neuronal apoptosis following controlled cortical impact brain injury in the mouse. J Neurotrauma 1998;15:599-614
5. Raghupathi R, Graham DI, McIntosh TK. Apoptosis after traumatic brain injury. J Neurotrauma 2000;17:927-38
6. Zhang X, Chen Y, Jenkins LW, et al. Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury. Crit Care 2005;9:66-75
7. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998;281:1305-8
8. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281: 1309-12
9. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001;410:37-40
10. Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell 2000;103:239-52
11. Bogoyevitch MA, Kobe B. Uses for JNK: The many and varied substrates of the c-Jun N-terminal kinases. Microbiol Mol Biol Rev 2006;70:1061-95
12. Lei K, Davis RJ. JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc Natl Acad Sci U S A 2003;100:2432-37
13. Chang L, Jones Y, Ellisman MH, et al. JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins. Dev Cell 2003;4:521-33
14. Yao M, Nguyen TV, Pike CJ. Beta-amyloid-induced neuronal apoptosis involves c-Jun N-terminal kinase-dependent downregulation of Bcl-w. J Neurosci 2005;25:1149-58
15. Yoshida H, Hastie CJ, McLauchlan H, et al. Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK). J Neurochem 2004;90:352-58
16. Raghupathi R, Muir JK, Fulp CT, et al. Acute activation of mitogen-activated protein kinases following traumatic brain injury in the rat: Implications for posttraumatic cell death. Exp Neurol 2003;183:438-48
17. Otani N, Nawashiro H, Fukui S, et al. Differential activation of mitogen-activated protein kinase pathways after traumatic brain injury in the rat hippocampus. J Cereb Blood Flow Metab 2002;22:327-34
18. Mori T, Wang X, Jung JC, et al. Mitogen-activated protein kinase inhibition in traumatic brain injury: In vitro and in vivo effects. J Cereb Blood Flow Metab 2002;22:444-52
19. Bonny C, Oberson A, Negri S, et al. Cell-permeable peptide inhibitors of JNK: Novel blockers of beta-cell death. Diabetes 2001;50:77-82
20. Borsello T, Clarke PG, Hirt L, et al. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med 2003;9:1180-86
21. Repici M, Centeno C, Tomasi S, et al. Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation. Neuroscience 2007;150:40-49
22. Longhi L, Perego C, Ortolano F, et al. C1-inhibitor attenuates neuro-behavioral deficits and reduces contusion volume after controlled cortical impact brain injury in mice. Crit Care Med 2009;37:659-65
23. Longhi L, Watson DJ, Saatman KE, et al. Ex vivo gene therapy using targeted engraftment of NGF-expressing human NT2N neurons attenuates cognitive deficits following traumatic brain injury in mice. J Neurotrauma 2004;21:1723-36
24. Barr RK, Kendrick TS, Bogoyevitch MA. Identification of the critical features of a small peptide inhibitor of JNK activity. J Biol Chem 2002; 277:10987-97
25. Fujimoto ST, Longhi L, Saatman KE, et al. Motor and cognitive function evaluation following experimental traumatic brain injury. Neurosci Biobehav Rev 2004;28:365-78
26. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501
27. Centeno C, Repici M, Chatton JY, et al. Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons. Cell Death Differ 2007;14:240-53
28. Beer R, Franz G, Krajewski S, et al. Temporal and spatial profile of caspase 8 expression and proteolysis after experimental traumatic brain injury. J Neurochem 2001;78:862-73
29. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81-84
30. Saatman KE, Duhaime AC, Bullock R, et al. Classification of traumatic brain injury for targeted therapies. J Neurotrauma 2008;25:719-38
31. Assimakopoulou M, Kondyli M, Gatzounis G, et al. Neurotrophin receptors expression and JNK pathway activation in human astrocytomas. BMC Cancer 2007;7:202
32. Smith DH, Soares HD, Pierce JS, et al. A model of parasagittal controlled cortical impact in the mouse: Cognitive and histopathologic effects. J Neurotrauma 1995;12:169-78
33. Gennarelli TA. Animate models of human head injury. J Neurotrauma 1994;11:357-68
34. Morales DM, Marklund N, Lebold D, et al. Experimental models of traumatic brain injury: Do we really need to build a better mousetrap? Neuroscience 2005;136:971-89
35. Mielke K, Herdegen T. JNK and p38 stress kinasesVdegenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol 2000;61:45-60
36. Beckham JD, Goody RJ, Clarke P, et al. Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase. J Virol 2007;81:6984-92
37. Hirt L, Badaut J, Thevenet J, et al. D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia. Stroke 2004;35:1738-43
38. Nawashiro H, Shima K, Chigasaki H. Selective vulnerability of hip-pocampal CA3 neurons to hypoxia after mild concussion in the rat. Neurol Res 1995;17:455-60
39. Lowenstein DH, Thomas MJ, Smith DH, et al. Selective vulnerability of dentate hilar neurons following traumatic brain injury: A potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci 1992;12:4846-53
40. Wang J, Van De Water TR, Bonny C, et al. A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss. J Neurosci 2003;23:8596-607
41. Suckfuell M, Canis M, Strieth S, et al. Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: A prospective randomized phase I/II study. Acta Otolaryngol 2007;127:938-42
42. Zhuang ZY, Wen YR, Zhang DR, et al. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: Respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 2006;26:3551-60
43. Milano G, Morel S, Bonny C, et al. A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo. Am J Physiol Heart Circ Physiol 2007;292: H1828-H1835.